Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-first microcap is using its balance sheet to accumulate BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Evoke Pharma Inc EVOK

Healthcare Drug Manufacturers - Specialty & Generic
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal... see more

Current News (NDAQ:EVOK)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:EVOK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EVOK)

A fight.

Morgan Stanley, Nantahala and insiders shares amounted to 40% of outstanding.  Not enough for merger. Morgan Stanley is selling on...
peterdaol - November 6, 2025

Gimoti the biomaiden.

7 years is the average lenght of times needed to bring a 20 years patented drug to market and that's exactly where this patented drug...
peterdaol - August 23, 2025

Selling product vs Selling shares?

Very odd that number of shares traded was 100 times of that's outstanding. This happened on every news release. They are making dough...
peterdaol - July 10, 2025

RE:RE:Using technical analysis for this stock.

It's not even 8 000 000. It's 1500 000!
peterdaol - July 9, 2025

RE:Using technical analysis for this stock.

Apart of the technicals, this is sharks feeding frenzy. 8 000 000 shares total and 130 000 000 shares are traded! This could be the hedge...
peterdaol - July 9, 2025

Using technical analysis for this stock.

BUY buddy buy because it's signalling a big uptrend from this point forward,so good luck to all shareholders out there since you...
coolfooldumbguy - July 9, 2025
View more Bullboard ››

Desert Gold Ventures Inc.

Desert Gold Ventures Inc.

Desert Gold Ventures Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts